345 related articles for article (PubMed ID: 15902108)
1. Elevated first-trimester nuchal translucency increases the risk of congenital heart defects.
Bahado-Singh RO; Wapner R; Thom E; Zachary J; Platt L; Mahoney MJ; Johnson A; Silver RK; Pergament E; Filkins K; Hogge WA; Wilson RD; Jackson LG;
Am J Obstet Gynecol; 2005 May; 192(5):1357-61. PubMed ID: 15902108
[TBL] [Abstract][Full Text] [Related]
2. Fetal cardiac defects and increased nuchal translucency thickness: a prospective study.
McAuliffe FM; Hornberger LK; Winsor S; Chitayat D; Chong K; Johnson JA
Am J Obstet Gynecol; 2004 Oct; 191(4):1486-90. PubMed ID: 15507988
[TBL] [Abstract][Full Text] [Related]
3. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of major heart defects by routine first-trimester ultrasound examination: association with increased nuchal translucency, tricuspid regurgitation and abnormal flow in ductus venosus.
Minnella GP; Crupano FM; Syngelaki A; Zidere V; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 May; 55(5):637-644. PubMed ID: 31875326
[TBL] [Abstract][Full Text] [Related]
5. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers.
Makrydimas G; Sotiriadis A; Huggon IC; Simpson J; Sharland G; Carvalho JS; Daubeney PE; Ioannidis JP
Am J Obstet Gynecol; 2005 Jan; 192(1):89-95. PubMed ID: 15672008
[TBL] [Abstract][Full Text] [Related]
6. Nuchal translucency and the risk of congenital heart disease.
Simpson LL; Malone FD; Bianchi DW; Ball RH; Nyberg DA; Comstock CH; Saade G; Eddleman K; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; D'Alton ME
Obstet Gynecol; 2007 Feb; 109(2 Pt 1):376-83. PubMed ID: 17267839
[TBL] [Abstract][Full Text] [Related]
7. [The role of fetal nuchal translucency (NT) and ductus venosus blood flow (DV) in the detection of congenital heart defects].
Baś-Budecka E; Perenc M; Sieroszewski P
Ginekol Pol; 2010 Apr; 81(4):272-6. PubMed ID: 20476599
[TBL] [Abstract][Full Text] [Related]
8. Abnormal first-trimester ductus venosus blood flow: a marker of cardiac defects in fetuses with normal karyotype and nuchal translucency.
Martínez JM; Comas M; Borrell A; Bennasar M; Gómez O; Puerto B; Gratacós E
Ultrasound Obstet Gynecol; 2010 Mar; 35(3):267-72. PubMed ID: 20052662
[TBL] [Abstract][Full Text] [Related]
9. Risk of critical congenital heart defects by nuchal translucency norms.
Jelliffe-Pawlowski LL; Norton ME; Shaw GM; Baer RJ; Flessel MC; Goldman S; Currier RJ
Am J Obstet Gynecol; 2015 Apr; 212(4):518.e1-10. PubMed ID: 25448520
[TBL] [Abstract][Full Text] [Related]
10. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
[TBL] [Abstract][Full Text] [Related]
11. Association between increased nuchal translucency and second trimester cardiac echogenic foci.
Prefumo F; Presti F; Thilaganathan B; Carvalho JS
Obstet Gynecol; 2003 May; 101(5 Pt 1):899-904. PubMed ID: 12738147
[TBL] [Abstract][Full Text] [Related]
12. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
[TBL] [Abstract][Full Text] [Related]
13. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
Zoppi MA; Ibba RM; Floris M; Monni G
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
[TBL] [Abstract][Full Text] [Related]
14. Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness.
Maiz N; Plasencia W; Dagklis T; Faros E; Nicolaides K
Ultrasound Obstet Gynecol; 2008 Mar; 31(3):256-60. PubMed ID: 18307193
[TBL] [Abstract][Full Text] [Related]
15. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.
Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K
Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183
[TBL] [Abstract][Full Text] [Related]
16. Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies.
Müller MA; Clur SA; Timmerman E; Bilardo CM
Prenat Diagn; 2007 Feb; 27(2):164-9. PubMed ID: 17238215
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome in apparently healthy children with increased nuchal translucency in the first trimester screening.
Äyräs O; Eronen M; Tikkanen M; Rahkola-Soisalo P; Paavonen J; Stefanovic V
Acta Obstet Gynecol Scand; 2016 May; 95(5):541-6. PubMed ID: 26918672
[TBL] [Abstract][Full Text] [Related]
18. Reliability of the first-trimester cardiac scan by ultrasound-trained obstetricians with high-frequency transabdominal probes in fetuses with increased nuchal translucency.
Bellotti M; Fesslova V; De Gasperi C; Rognoni G; Bee V; Zucca I; Cappellini A; Bulfamante G; Lombardi CM
Ultrasound Obstet Gynecol; 2010 Sep; 36(3):272-8. PubMed ID: 20499407
[TBL] [Abstract][Full Text] [Related]
19. Fetal echocardiography at the time of the nuchal translucency scan.
Lombardi CM; Bellotti M; Fesslova V; Cappellini A
Ultrasound Obstet Gynecol; 2007 Mar; 29(3):249-57. PubMed ID: 17318942
[TBL] [Abstract][Full Text] [Related]
20. Nuchal Translucency and Congenital Heart Defects.
Sofia-Gonçalves A; Guedes-Martins L
Curr Cardiol Rev; 2024; 20(2):1-13. PubMed ID: 38275068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
